Drug General Information (ID: D1059)
  Drug Name
Microcrystalline cellulose
  Drug Type Small molecule
  Drug Synonymous
1333-74-0; H; Hydrogen; Molecular hydrogen; Dihydrogen; Atomic hydrogen; H2; Microcrystalline cellulose; Polystyrene,mw 190000; Hydrogen gas; Hydrogen, atomic; hidrogeno; hydrogene; Wasserstoff; alpha-cellulose; Polystyrene,; Cellulose powder; o-Hydrogen; p-Hydrogen; hydrogen molecule; Elemental hydrogen; Powdered cellulose; monoatomic hydrogen; 3A molecular sieve; Polystyrene, HIPS; Polystyrene,1000; Cellulose Nanoparticles; Latex beads,polystyrene; Polystyrene,mw 1200; alpha-Cellulose, 90mum; Polystyrene,mw 45000; Polystyrene,atactic pellets; T101 Monoclonal Antibody; Polystyrene,mw 210000; Polystyrene,mw 260000; Polystyrene,mw 50,000; COware 20ml with H-Caps; Polystyrene, extrusion grade; Polystyrene latex microsphere; Hydrogen, >=99.99%; Hydrogen, >=99.999%; Poly[titanium(IV) n-butoxide]; Polystyrene,mw 800-5,000; DTXSID9029643; CHEBI:18276; CHEBI:33251; CHEBI:49637; Polystyrene,monohydroxy terminated; DTXSID501014229; Cellulose Nanopowder / Nanoparticles; BBL103822; NSC356464; Polystyrene syndiotactic,mw 300000; STL557632; alpha-Cellulose, 25mum particle size; alpha-Cellulose, 65mum particle size; Latex beads,amine-modified polystyrene; AKOS016038407; MCULE-3166658688; NSC-356464; Polystyrene, General-II, high strength; UN 1049; UN 1966; E949; Hydrogen, Messer(R) CANgas, 99.999%; Latex beads,carboxylate-modified polystyrene; E 949; E-949; Polystyrene,monohydroxy terminated,mw 10000; Polystyrene, General-I, for injection molding; C00282; Polystyrene,monomethacrylate terminated,mw 15000; alpha-Cellulose, Partical size: d50,180-280mum; alpha-Cellulose, Partical size: d50,90-150mum; Q3027893; Latex beads,polystyrene, diameter 9.0-9.9mum ,5% w/v; Latex beads,polystyrene, diameter 1.0 - 1.9mum ,5% w/v; Latex beads,polystyrene, diameter 2.0- 2.9 mum ,5% w/v; Latex beads,polystyrene, diameter 3.0 - 3 .9mum ,5% w/v; Latex beads,polystyrene, diameter 4.0 - 4.9mum ,5% w/v; Latex beads,polystyrene, diameter 6.0 - 6.9mum ,5% w/v; Latex beads,polystyrene, diameter 7.0 - 7.9mum ,5% w/v; Latex beads,polystyrene, diameter 8.0 - 8.9mum ,5% w/v; Latex beads,polystyrene, diameter 9.0-9.9mum ,2.5% w/v; Latex beads,polystyrene, diameter 0.05 - 0.1mum ,2.5% w/v; Latex beads,polystyrene, diameter 0.2 - 0.5mum ,2.5% w/v; Latex beads,polystyrene, diameter 0.6 - 1.0 mum ,2.5% w/v; Latex beads,amine-modified polystyrene, diameter >10mum ,2.5% w/v; Latex beads,amine-modified polystyrene, diameter 0.05 - 0.1mum ,2.5% w/v; Latex beads,amine-modified polystyrene, diameter 0.2 - 0.5mum ,2.5% w/v; Latex beads,amine-modified polystyrene, diameter 0.6 - 1.0mum,2.5% w/v; Latex beads,amine-modified polystyrene, diameter 1.0 - 1.9mum,2.5% w/v; Latex beads,amine-modified polystyrene, diameter 2.0 - 2.9mum,2.5% w/v; Latex beads,amine-modified polystyrene, diameter 3.0 - 3.9mum,5% w/v; Latex beads,amine-modified polystyrene, diameter 4.0 - 4.9mum,5% w/v; Latex beads,amine-modified polystyrene, diameter 6.0 - 6.9mum,5% w/v; Latex beads,amine-modified polystyrene, diameter 7.0 - 7.9mum,5% w/v; Latex beads,amine-modified polystyrene, diameter 8.0 - 8.9mum,5% w/v; Latex beads,amine-modified polystyrene, diameter 9.0 - 9.9mum,5% w/v; Latex beads,carboxylate-modified polystyrene, diameter >10mum ,2.5% w/v; Latex beads,carboxylate-modified polystyrene, diameter 1.0 - 1.9mum,5% w/v; Latex beads,carboxylate-modified polystyrene, diameter 3.0 - 3.9mum,5% w/v; Latex beads,carboxylate-modified polystyrene, diameter 4.0 - 4.9mum,5% w/v; Latex beads,carboxylate-modified polystyrene, diameter 5.0 - 5.9mum,5% w/v; Latex beads,carboxylate-modified polystyrene, diameter 6.0 - 6.9mum,5% w/v; Latex beads,carboxylate-modified polystyrene, diameter 7.0 - 7.9mum,5% w/v; Latex beads,carboxylate-modified polystyrene, diameter 8.0 - 8.9mum,5% w/v; Carboxylated polystyrene latex particles of blue, diameter 6.0 - 6.9mum, 2.5% w/v; Latex beads,carboxylate-modified polystyrene, diameter 0.05 - 0.1mum ,2.5% w/v; Latex beads,carboxylate-modified polystyrene, diameter 0.2 - 0.5mum ,2.5% w/v; Latex beads,carboxylate-modified polystyrene, diameter 0.6 - 1.0mum,2.5% w/v; Latex beads,carboxylate-modified polystyrene, diameter 2.0 - 2.9mum,2.5% w/v; Latex beads,carboxylate-modified polystyrene, diameter 9.0 - 9.9 mum,5% w/v; 1H; H-H
    Click to Show/Hide
  Therapeutic Class Excipients
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula H2
  InChI InChI=1S/H2/h1H
  InChIKey UFHFLCQGNIYNRP-UHFFFAOYSA-N
  Canonical SMILES [HH]
  External Link
Pubchem ID 783

Drug-Drug Interaction Network
  Sunburst Graph
AM003  Affected organization distribution
AM006  Pharmacodynamic additive effects
BM014  Interference of cell/tissue uptake
BM109  Increased risk of other adverse reactions (Unspecific)
  Relation Graph
 Full list of drugs interacting with Microcrystalline cellulose
      Affected organization distribution
   Interference of cell/tissue uptake Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0670
 
Fludeoxyglucose (18F)
 
C6H11FO5
 
170049 
Moderate    Inter Info   
[1], [2], [3]
      Pharmacodynamic additive effects
   Increased risk of other adverse reactions (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0929
 
Linaclotide
 
C59H79N15O21S6
 
16158208 
Minor    Inter Info   
[4], [5]
References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Multum Information Services, Inc. Expert Review Panel.
3 Product Information. Metamucil (psyllium). Procter and Gamble Pharmaceutic, Cincinnati, OH.
4 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
5 Product Information. Linzess (linaclotide). Forest Pharmaceuticals, St. Louis, MO.